Small molecule inhibitors and CRISPR/Cas9 mutagenesis demonstrate that SMYD2 and SMYD3 activity are dispensable for autonomous cancer cell proliferation
Keyword(s):
2021 ◽
Vol 4
(2)
◽
pp. 744-756
2014 ◽
Vol 50
(14)
◽
pp. 2463-2477
◽
2014 ◽
Keyword(s):
2016 ◽
Vol 83
◽
pp. 1038-1047
◽
Keyword(s):
2019 ◽
Vol 85
(1)
◽
pp. 47-59
◽